Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,000.00    -25.00 (-0.41%)
Bid:
5,995.00
Ask:
6,000.00
Spread: 5.00 (0.083%)
Market Cap: £5.13b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Interim Management Statement

4 Feb 2020 07:00

RNS Number : 8187B
DCC PLC
04 February 2020
 

 

 

 

4 February 2020

 

DCC plc

 

Interim Management Statement

 

Trading in line with expectations

 

DCC plc, the leading international sales, marketing and support services group, is issuing this Interim Management Statement for the third quarter ended 31 December 2019.

 

Third quarter ended 31 December 2019

Notwithstanding the more difficult macroeconomic environment, particularly in the UK, and relatively mild weather conditions, DCC delivered a good trading performance in the third quarter of the financial year and Group operating profit for the period was in line with expectations.

 

DCC LPG continued to perform strongly and delivered good organic profit growth and also benefited from the contribution of Pacific Coast Energy, acquired earlier in the financial year. DCC Retail & Oil performed in line with expectations and benefitted from a good performance from the division's retail activities. Following the disposal of its UK generic pharma business during the first half of the year, DCC Healthcare delivered good like-for-like profit growth and successfully completed the previously announced acquisition of Ion Labs during the quarter. As anticipated, trading in DCC Technology's UK business was impacted by the general weakness in the UK technology market, reflecting the more difficult economic environment. The remainder of the Technology division recorded good growth.

 

DCC has grown substantially in recent years and now has significant operations across 20 countries, with market-leading positions in each of its LPG, Retail & Oil, Technology and Healthcare divisions. DCC's ambition and capacity for further development, together with the Group's leading market positions and increased geographic reach, provide substantial opportunity for the continued growth and development of the business.

 

Year ending 31 March 2020

Assuming normal weather conditions for the balance of the financial year, the Group reiterates its belief that the year ending 31 March 2020 will be another year of development and good growth in Group operating profit, in line with current market consensus expectations.

 

Final results

DCC expects to announce its results for the year ending 31 March 2020 on 19 May 2020.

 

 

For reference:

Donal Murphy, Chief Executive

Fergal O'Dwyer, Chief Financial Officer

Kevin Lucey, Head of Capital Markets

 

Telephone: +353 1 2799400

Email: investorrelations@dcc.ie

Web: www.dcc.ie

 

Powerscourt (Media)

Lisa Kavanagh / Victoria Palmer-Moore

 

Telephone: +44 20 7250 1446

Email: DCC@powerscourt-group.com

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology.

 

DCC is an ambitious and entrepreneurial business operating in 20 countries, supplying products and services used by millions of people every day. Building strong routes to market, driving for results, focusing on cash conversion and generating superior sustainable returns on capital employed enable the Group to reinvest in its business, creating value for its stakeholders.

 

Headquartered in Dublin, employing approximately 13,000 people, DCC's four divisions are:

DCC LPG - a leading LPG sales and marketing business with operations in Europe, the US and Asia and a developing business in the retailing of natural gas and electricity;DCC Retail & Oil - a leader in the sales, marketing and retailing of transport fuels and commercial fuels, heating oils and related products and services in Europe;DCC Technology - a leading route-to-market and supply chain partner for global technology brands and customers; andDCC Healthcare - a leading healthcare business, providing products and services to healthcare providers and health and beauty brand owners.

 

DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2019, DCC generated revenue of £15.2 billion and operating profit of £460 million.

 

DCC has an excellent record, delivering compound annual growth of 14% in operating profit and generating an average return on capital employed of approximately 19% over 25 years as a public company.

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDXLFBBLLXBBB
Date   Source Headline
24th Nov 20255:26 pmRNSHolding in Company TR-1
21st Nov 20255:36 pmRNSHolding in Company TR-1
19th Nov 202510:16 amRNSHolding in Company TR-1
18th Nov 20256:05 pmRNSHolding in Company TR-1
17th Nov 20257:00 amRNSProposed return of up to £600m by tender offer
13th Nov 20255:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSResults for the six months ended 30 September 2025
3rd Nov 20257:00 amRNSCompletion of sale of Info Tech business
21st Oct 202512:30 pmRNSLiquid Gas Acquisitions
17th Oct 20259:50 amRNSHolding in Company TR-1
17th Oct 20257:00 amRNSDirector Declaration
15th Oct 20253:38 pmRNSHolding in Company TR-1
13th Oct 202512:45 pmRNSHolding in Company TR-1
7th Oct 20252:00 pmRNSHolding in Company TR-1
3rd Oct 20254:30 pmRNSHolding in Company TR-1
1st Oct 202512:43 pmRNSHolding in Company TR-1
25th Sep 20254:02 pmRNSHolding in Company TR-1
22nd Sep 20256:09 pmRNSHolding in Company TR-1
22nd Sep 202511:20 amRNSHolding in Company TR-1
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSDCC Healthcare sale completes and capital return
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202510:56 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20256:11 pmRNSHigh Court Approval of Reduction of Capital
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.